Читать книгу Anti-Aging Therapeutics Volume XVII - A4M American Academy - Страница 8

Silicon Valley and Fortune 500 companies commit over US $6 Billion to efforts to reveal effective therapies to reverse and cure aging. These significant funds must not be squandered, as was the $1 Trillion spent on the War on Cancer of the 1970s – that yielded limited applicable discoveries. The public must demand, and expect transparency in human aging intervention so that breakthroughs are shared with the public without delay and without obfuscation, and without the political agendas that continue to thwart true innovation and rapid advances seen in other scientific fields such as physics, microelectronics and computing – but seemingly withheld by establishment medicine,

A4M wrote the history of longevity medicine and remains positioned to lead the clinical specialty via its educational programming. The entirely novel marketplace of anti-aging, which stood at zero dollars prior to 1991 (the year A4M was established), is valued at $250 Billion (2012). The sector is projected to grow at a compound annual growth rate of 5.7%, to top $345 billion in 2018.⁶